We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC OKs $76M Astellas-Maxygen Protein Program Deal

Law360 (March 29, 2011, 2:01 PM EDT) -- The Federal Trade Commission granted an early termination on Monday to the 30-day waiting period before Astellas Pharma Inc. can complete its $76 million purchase of all of Maxygen Inc.’s equity...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.